Results 151 to 160 of about 17,628 (210)

Synchronous Low-Grade Appendiceal Mucinous Neoplasm and Neuroendocrine Tumor Presenting as Pseudomyxoma Peritonei: A Case Report. [PDF]

Cureus
Stevens T, Fleury L, Collera J, Jagodzinski K, Fan J.   +4 more
europepmc   +1 more source

ASO Author Reflections: Surgical Radicality Versus Aggressive Biology: Small Bowel and Ileocecal Involvement Predict Poorer Survival Despite Complete Cytoreduction in FIGO IIIC-IV Tubo-Ovarian and Primary Peritoneal Carcinoma. [PDF]

Ann Surg Oncol
Runnebaum IB, Kather A.
europepmc   +1 more source

Long-term outcomes, pathological classification and prognostic factors in localised and advanced appendiceal goblet cell adenocarcinoma following cytoreductive surgery, intraperitoneal and systemic chemotherapy. [PDF]

ESMO Open
Strach MC, Aziz O, Nonaka D, Nagaraju RT, Clouston H, Mullamitha S, Braun M, Chakrabarty B, O'Dwyer ST, Barriuso J.   +9 more
europepmc   +1 more source

Hydroxyurea Bridging Before Frontline Tyrosine Kinase Inhibitor Therapy in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: A Critical Appraisal.

Oncology
Abdulgayoom M, Alshurafa A, Al-Mashdali AF, F Mohamed S, Yassin MA.   +4 more
europepmc   +1 more source

Achieving Complete Cytoreduction After Systemic Therapy for Stage IV Renal Carcinoma With Multicompartment Recurrence and Peritoneal Carcinomatosis: A Case Report. [PDF]

Case Rep Oncol Med
Usubillaga JP, Varela R, Reina Y, Franco DC, Valderrama JS, Zapata-Laguado M, Suso-Palau D.   +6 more
europepmc   +1 more source

The Shifting Landscape of Debulking Surgery in Newly Diagnosed Advanced Ovarian Cancer. [PDF]

Cancers (Basel)
Tsolakidis D, Zouzoulas D.
europepmc   +1 more source

Impact of Accumulated Institutional Experience on Outcomes of Cytoreductive Surgery with Intraperitoneal Chemotherapy for Colorectal and Appendiceal Peritoneal Metastases: Early Versus Later Cohort Analysis. [PDF]

Cancers (Basel)
Suh JW, Kang H, Namgung H, Jo JW, Lee SC, Park DG.   +5 more
europepmc   +1 more source

A decision-support tool for management of advanced epithelial ovarian cancer in a single centre in India (CT PAUSE Nomogram): a prospective Study (2022-2024). [PDF]

Lancet Reg Health Southeast Asia
Jeslin AG, Natarajan S, Hiriyanna S, Ninan R, Cecil GH, Simon B, Eapen A, Thomas V, Thomas A, Varghese KM, Joel A, Singh A, Karuppusami R, Chandramohan A.   +13 more
europepmc   +1 more source